Humacyte (HUMA) Other Operating Expenses (2020 - 2026)
Humacyte (HUMA) reported Other Operating Expenses of $2.0 million for Q1 2026, up 1286.39% year-over-year from $147000.0 in Q1 2025, and down 77.56% quarter-over-quarter from $9.1 million in Q4 2025.
Humacyte (HUMA) Other Operating Expenses (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has 3 years of Other Operating Expenses data on file, last reported at $2.0 million in Q1 2026.
- Other Operating Expenses for Q1 2026 came in at $2.0 million, up 1286.39% year-over-year; the trailing twelve-month figure through Mar 2026 was $11.6 million (up 7786.39% YoY), and the FY2025 annual result was $9.7 million, changed N/A from the prior year.
- Other Operating Expenses slipped to $2.0 million in Q1 2026 per HUMA's latest filing, from $9.1 million in the prior quarter.
- Over five years, Other Operating Expenses peaked at $9.1 million in Q4 2025 and troughed at $147000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Humacyte | 183.21 Mn | 134.67 Mn | -1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.04 Mn |
| Dec 31, 2025 | 9.08 Mn |
| Sep 30, 2025 | 260,000.00 |
| Jun 30, 2025 | 213,000.00 |
| Mar 31, 2025 | 147,000.00 |
| Dec 31, 2020 | 1.65 Mn |
| Sep 30, 2020 | -99,044.00 |